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Abstract
Background Phlebitis is a common complication in patients with 
peripheral intravenous catheters, in addition to extravasation and 
bacterial colonization. Phlebitis may increase morbidity and length 
of hospitalization. One factor contributing to the rate of phlebitis is 
the duration of peripheral intravenous catheter use. Several adult 
studies have shown that the risk of developing phlebitis increased 
when the peripheral intravenous catheter was used for more than 
KRXUV+RZHYHULQSHGLDWULFSDWLHQWVWKLVULVNKDVQRWEHHQ
consistently observed. As such, there is no recommendation for 
URXWLQHFDWKHWHUUHPRYDOHYHU\KRXUVLQFKLOGUHQ
Objective To assess for a possible relationship between duration 
of peripheral intravenous catheter use and the development of 
phlebitis.
Methods This analytic observational study had a case control 
GHVLJQ6XEMHFWVFRQVLVWHGRIFDVHVXEMHFWVDQGFRQWURO
VXEMHFWV:HFROOHFWHGVXEMHFWV·GDWDWKURXJKKLVWRU\WDNLQJDQG
clinical examinations. The duration of peripheral intravenous 
catheter use was reported in hours.
Results)URP2FWREHUWR)HEUXDU\FKLOGUHQIURP
the Department of Child Health at Dr. Cipto Mangunkusumo 
Hospital and Tangerang Hospital who used peripheral intravenous 
catheters were enrolled in this study. There was no significant 
GLIIHUHQFHEHWZHHQKRXUDQGKRXUGXUDWLRQRI
SHULSKHUDOFDWKHWHUXVH25&,WR
3 RQWKHGHYHORSPHQWRISKOHELWLV
Conclusion We observe no relationship between duration of 
peripheral intravenous catheter use and the development of 
SKOHELWLVLQRXUVXEMHFWV[Paediatr Indones. 2013;53:117-
20.].
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P
eripheral intravenous catheters are generally 
inserted into a peripheral vein and used for 
continuous or intermittent treatments.0DMRU
complications associated with these catheters are 
phlebitis, extravasation, and bacterial colonization, as 
well as development of catheter-related bloodstream 
infections (CRBSI).3%RHGMDQJUHSRUWHGWKHSUHYDOHQFH
RISKOHELWLVZDVIROORZHGE\LQILOWUDWLRQUDWHRI
DQGEDFWHUHPLDUDWHRIDPRQJQHRQDWHV
hospitalized in the Neonatal Intensive Care Unit 
(NICU) at Cipto Mangunkusumo Hospital.4
  One factor related to the development of 
phlebitis is duration of peripheral intravenous catheter 
use. Adult studies have reported a relationship be-
tween the duration of peripheral inravenous catheter 
use and the development of phlebitis. It has been sug-
JHVWHGWKDWFDWKHWHUVVKRXOGEHUHPRYHGHYHU\
hours to reduce the risk of phlebitis, but there has 
been no such recommendation for children.5Other
adult studies reported contradictory results, suggest-
ing that female gender or diagnosis of infection were 
factors related to phlebitis, while other studies showed 
no such relationship to phlebitis.6 There has been no Rita Andriyani et al: Duration of peripheral intravenous catheter use and development of phlebitis
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characteristics of pediatric patients shown to correlate 
to phlebitis.
The purpose of this study was to evaluate a 
possible association between duration of peripheral 
intravenous cathether use and the development of 
phlebitis in pediatric patients. In addition, we assessed 
if pediatric patient characteristics such as age, gender, 
diagnosis group or nutritional status were related 
to phlebitis in patients with peripheral intravenous 
catheters.
Methods
7KLVZDVDFDVHFRQWUROVWXG\RQDOOVXEMHFWVXVHG
SHULSKHUDOLQWUDYHQRXVFDWKHWHUVDJHG!GD\V
years and were hospitalized in the Department of 
Child Health wards at Cipto Mangunkusumo Hospital 
DQG7DQJHUDQJ+RVSLWDO6XEMHFWVZLWKSKOHELWLVEDVHG
on the diagnosis criteria of phlebitis were matched 
ZLWKDFRQWUROVXEMHFWLQWKHVDPHDJHJURXSZKRKDG
similar nutritional status. The early stage showed at 
least two of the following signs: pain at intravenous 
site, erythema, or swelling. The medium stage 
showed pain along path of cannula, erythema, and 
induration, while the late stage of phlebitis showed 
all the signs above with the palpable venous cord. 
Thrombophlebitis occured when all the signs showed 
with fever. We recorded the duration of peripheral 
intavenous catheter use and other characteristics by 
history-taking, as well as from the medical records of 
VXEMHFWVLQERWKJURXSV7KHUHZHUHVXEMHFWVLQ
WKHFDVHJURXSDQGVXEMHFWVLQWKHFRQWUROJURXS
meeting the required sample size for our study. The 
relationship between dependent and independent 
variables were analyzed by Chi square test, with a 
3YDOXHRILQDFRQILGHQFHLQWHUYDOZDV
considered to be statistically significant.
Results
'XULQJWKHVWXG\SHULRGEHWZHHQ2FWREHUWR
)HEUXDU\ZHFROOHFWHGVXEMHFWVRIZKRP
VXEMHFWVKDGSKOHELWLVFDVHJURXSDQGVXEMHFWV
served as a matched control group. Median age in 
WKHFDVHJURXSZDV\HDUDQGPRQWKVUDQJH
PRQWKV\HDUV&KDUDFWHULVWLFVRIVXEMHFWVDUH
shown in Table 1.
We found that the median duration of catheter 
use for development of phlebitis was 66 hours (2 days 
DQGKRXUVUDQJLQJIURPKRXUVWRKRXUV
GD\VKRXUVLQRXUVXEMHFWV:HGHILQHGFDWKHWHU
XVHGXUDWLRQDVKRXUVRUKRXUV&KLVTXDUH
test revealed that there was no significant difference 
between the phlebitis and non-phlebitis groups in 
terms of duration of catheter use >KRXUV25
&,WR3 7KHORFDWLRQ
RIFDWKHWHULQVHUWLRQLQPRVWVXEMHFWVZDVLQWKHXSSHU
extremities, rather than in the lower extremities, 
and was not significantly different (OR &,
WR3 between the case and control 
JURXSV1RVXEMHFWVKDGFDWKHWHUVLQVFDOSYHLQV
&KLVTXDUHWHVWUHYHDOHGWKDWVXEMHFWV·JHQGHUVZHUH
Table 1. Characteristics of subjects 
Characteristics Case group
 (n=73)
Control group
 (n=73),
Age
        Median  1 year 6 months 1 year 9 months
        Range 2 months-16 years 1 month-16 years
Gender, n (%)
        Male 43 (58.9) 31 (42.5)
        Female 30 (41.1) 42 (57.5)
Diagnosis group, n (%)
        Infection 40 (54.8) 44 (60.3)
        Non-infection 33 (45.2) 29 (39.7)
Nutritional status, n (%)
       Severely malnourished   6 (8.2)   6 (8.2)
       Malnourished 15 (20.5) 15 (20.5)
       Well nourished 52 (71.2) 52 (71.2)Rita Andriyani et al: Duration of peripheral intravenous catheter use and development of phlebitis
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significantly different (OR &,WR
3 between the two groups, with more males in 
the case group than in the control group (Table 2).
We recorded the intravenous medications 
DQGIOXLGWKDWVXEMHFWVKDGUHFHLYHGZKHQSKOHELWLV
developed and categorized them into chemotherapy 
drugs, non-chemotherapy drugs, fluid or blood 
products. In both groups, non-chemotherapy drugs 
were the most common medication given (Table 
3).
:HIRXQGWKDWPRVWVXEMHFWVLQWKHFDVHJURXS
were in an early stage of phlebitis. No thrombophlebitis 
ZDVIRXQGLQRXUVXEMHFWVFigure 1). 
Discussion
'XULQJWKHVWXG\SHULRGZHHQUROOHGVXEMHFWV
RIZKLFKVXEMHFWVKDGSKOHELWLVFDVHJURXSDQG
UHPDLQLQJVXEMHFWVVHUYHGDVWKHFRQWUROJURXS7KH
PHGLDQDJHRIWKHFDVHJURXSZDV\HDUDQGPRQWKV
UDQJHPRQWKV\HDUVDQGZDVQRWVLJQLILFDQWO\
different from that of the control group with median 
DJH\HDUDQGPRQWKVUDQJHPRQWK²\HDUV
,QERWKJURXSVPRVWVXEMHFWVZHUHPRQWK\HDUV
of age. In infants, it is often more difficult to insert 
peripheral intravenous catheters due to their tiny and 
fragile veins. It may be difficult to properly localize 
their veins when inserting a catheter, making it easier 
for them to develop phlebitis.
The case group had significantly more male 
VXEMHFWVWKDQWKDWRIWKHFRQWUROJURXS,QFRQWUDVWD
VWXG\RIDGXOWVLQ,UDQVKRZHGWKDWWKHGHYHORSPHQW
of phlebitis was associated with female gender, and 
related to hormonal status.6,QRXUVWXG\PRVWVXEMHFWV
Table 2. Factors assessed for an association to the development of phlebitis
Variables
Case group
 (n=73)
Control group
 (n=73)
P value OR (95% CI)
Duration of catheter use, n (%)
        <72 hours 41 (56.1) 36 (49.3) 0.407* 1.31   (0.687-2.526)
ŮJQWTU 32 (43.8) 37 (50.6)
Inserted location, n (%) 
       Upper extremity 65 (89) 66 (90.4) 0.785* 0.862 (0.295-2.514)
       Lower extremity   8 (11)   7 (9.6)
Gender, n (%)
       Male  43 (58.9) 31 (42.5) 0.047* 1.942 (1.006-3.749)
       Female 30 (41.1) 42 (57.5)
*Chi squaretest
Table 3. Distribution of KPVTCXGPQWUOGFKECVKQPUCPFƀWKF
Intravenous products
Case group
(n)
Control group
(n)
Medications
        Chemotherapy 22 30
        Non-chemotherapy 90 81
Fluid
        Isotonic solution 59 69
        Hypertonic solution (non-blood product)   9   9
Blood products 26 11
Figure 1. Distribution of stages of phlebitisRita Andriyani et al: Duration of peripheral intravenous catheter use and development of phlebitis
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ZHUHDJHGPRQWK\HDUVVRWKH\ZHUHOLNHO\QRW\HW
influenced by their pubertal hormonal status.
0RVWVXEMHFWVKDGEHHQGLDJQRVHGZLWKLQIHFWLRXV
diseases. antibiotic treatment of these patients may 
have led to the development of chemical phlebitis. 
0RVWVXEMHFWVIURPERWKJURXSVZHUHZHOOQRXULVKHG
Nutritional status was matched between the case and 
FRQWUROVXEMHFWVVLQFHLWLVWKRXJKWWKDWPDOQRXULVKHG
patients would be more susceptible to infectious 
disease.
We found no difference in the percentage of 
patients who had catheter duration of >KRXUVLQ
the phlebitis group compared to the control group. This 
result was similar to that of another study that showed 
WKDWD!KRXUGXUDWLRQRISHULSKHUDOLQWUDYHQRXV
catheter use was not associated with the development of 
phlebitis.8Based on these results, we suggest that it is not 
QHFHVVDU\WRUHPRYHFDWKHWHUVHYHU\KRXUVLQFKLOGUHQ
as long as observation is done vigilantly to examine for 
signs of phlebitis. If signs of phlebitis are found, the 
catheter should be removed. At the Department of Child 
Health, Cipto Mangunkusumo Hospital, this is currently 
our standard operating procedure.  Prior to the year 
RIZHURXWLQHO\UHPRYHGSHULSKHUDOLQWUDYHQRXV
FDWKHWHUVHYHU\KRXUV
In the case group, non-chemotherapy drugs were 
the most common drugs given. A limitation of our 
study was that we were unable to determine which 
drugs or fluid influenced the development of phlebitis, 
since all drugs/fluid were often given through the same 
route and at the same time. 
:HIRXQGWKDWPRVWRIWKHFDVHVXEMHFWVZHUHDWDQ
early stage of phlebitis. This condition was to be expected 
if medical workers were adequately observing the patients 
and looking for signs of phelbitis. No thrombophlebitis 
ZDVIRXQGLQRXUVXEMHFWVGXULQJWKLVVWXG\
Another limitation of our study was that the 
VXEMHFWVZHUHREWDLQHGIURPGLIIHUHQWKRVSLWDOVZKLFK
may have differed in terms of staff hand hygiene, 
sanitation, and other factors related to the development 
of phlebitis. Also, researchers examining and diagnosing 
SKOHELWLVPD\KDYHGLIIHUHGLQFOLQLFDOMXGJPHQW
We found no relationship between the duration 
of peripheral intravenous catheter use and the 
GHYHORSPHQWRISKOHELWLVLQRXUSHGLDWULFVXEMHFWV 
Therefore, we conclude that peripheral intravenous 
catheter may continue to be used as long as there is 
no sign of phlebitis. Careful and vigilant observation 
of the catheter must be undertaken and the catheter 
should be removed at the first sign of phlebitis.
References
 &DWQH\05+LOOLV6:DNHILHOG%6LPSVRQ/'RPLQR/
Keller S, et al. Relationship between peripheral intravenous 
catheter dwell time and the development of phlebitis and 
LQILOWUDWLRQ-,QIXV1XUV
2.  Mermel LA, Farr BM, Sheretz RJ, Raad II, O’Grady 
NO, Harris JS, et al. Guidelines for the management of 
intravascular catheter-related infections. Clin Infect Dis. 

3.  O’Grady NP , Alexander M, Dellinger EP , Gerberding JL,
Heard SO, Maki DG, et al. Guidelines for the prevention 
of intravascular catheter-related infections. Pediatrics. 
H
 %RHGMDQJ5)1RVRFRPLDOLQIHFWLRQVIURPLQWUDYHQRXV
FDWKHWHU3DHGLDWU,QGRQHV
5.  O’Grady NP , Alexander M,BurnsLA, Dellinger EP , Garland 
J, Heard SO,et al. Guidelines for prevention of intravascular 
FDWKHWHUUHODWHGLQIHFWLRQ&OLQ,QIHFW'LVH

 1DVVDML=DYDUHK0*KRUEDQL53HULSKHUDOLQWUDYHQRXV
catheter-related phlebitis and related factors. Singapore Med  
-
 /DPDJQD3 0DF3KHH07URXEOHVKRRWLQJSHGLDWULF
SHULSKHUDO,9VSKOHELWLVDQGLQILOWUDWLRQ>FLWHG0DUFK
@$YDLODEOHIURPhttp://news.nurse.com/apps/pbcs.dll/
article?AID
8.  Maki DG, Ringer M. Risk factors for infusion-related phlebitis 
with small peripheral venous catheters. A randomized 
FRQWUROOHGWULDO$QQ,QWHUQ0HG